- Home
- GOSS vs OKYO Comparison
GOSS vs OKYO Comparison
Compare GOSS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOSS | OKYO |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.8M | 89.7M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GOSS | OKYO |
|---|---|---|
| Price | $0.17 | $1.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $4.19 | ★ $6.33 |
| AVG Volume (30 Days) | ★ 15.1M | 60.3K |
| Earning Date | 05-07-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,471,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $201.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.14 | $1.42 |
| 52 Week High | $3.87 | $3.35 |
Technical Indicators
Market Signals| Indicator | GOSS | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 47.16 |
| Support Level | $0.16 | $1.47 |
| Resistance Level | $0.36 | $1.73 |
| Average True Range (ATR) | 0.02 | 0.10 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 47.73 | 45.76 |
Price Performance
Historical ComparisonAbout GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.